Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.
Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.: Treatment of identified conditions, i.e. fracture fixation, arthrodesis, osteotomy, with a cannulated screw.
Study summary
The objective of this retrospective enrollment/prospective follow up study is to collect data confirming safety, performance, and clinical benefits of the Biomet Cannulated Bone Screw System (Implants and Instrumentation) when used according to the approved Indications for Use (IFU).
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Patient must be 18 years of age or older.
All patients operated on for the following indications:
* Group 1, Small Cannulated Screws (4.0mm and smaller diameter) are intended for use in:
1. Fixation of small bones, including those in the foot, patella, ankle, wrist and elbow.
2. Arthrodesis of the foot, wrist and elbow.
3. Small and long bone osteotomies.
4. Fracture fixation of small bones, small bone fragments and long bones.
* Group 2, Large Cannulated Screws (5mm and larger in diameter) are intended for use in:
1. Fixation of fractures in long bones and long bone fragments.
2. Long bone osteotomies (femur, tibia, foot, ankle, olecranon).
3. Arthrodesis and fracture fixation of the foot and ankle, such as Jones fractures of the fifth metatarsal, and Calcaneal fractures.
* Group 3, Large Cannulated Screws (6.5mm and larger in diameter) are intended for use in:
1. Slipped capital femoral epiphysis
2. Pediatric femoral neck fractures
3. Tibial plateau fractures
4. SI joint disruptions
5. Intercondylar femur fractures
6. Subtalar arthrodesis
7. Fixation of pelvis and iliosacral joint
* Patients must have the ability and willingness to follow instructions, including control of weight and activity levels.
* Patient must have a good nutritional state.
Exclusion Criteria:
* Infections.
* Patient conditions including blood supply limitations, insufficient quantity or quality of bone.
* Patients with mental or neurologic conditions who are unwilling or incapable fo following postoperative care instructions.
* Foreign body sensitivity where material sensitivity is suspected or unknown, testing is to be completed prior to implantation of the device.
* Patient is a prisoner.
* Patient is a current alcohol or drug abuser.
* Patient is known to be pregnant or breastfeeding.
* Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent.
Primary outcome measure(s)
Device Safety Assessed Through the Incidence and Frequency of Revisions, Complications, and Adverse Events — Out to12+ months Assessment of safety by recording and analyzing the incidence and frequency of revisions, complications, and adverse events.
Trial sites (3)
Facility
City
Region
Status
Zimmer Biomet
Warsaw
Indiana
Orthopedic Foot and Ankle Center
Worthington
Ohio
Associated Foot & Ankle Centers of Northern Virginia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.